December 18, 2019 — Append Medical, developer of a novel left atrial appendage (LAA) closure device to minimize stroke risk in atrial fibrillation (AF) patients, announced that it has been selected from among hundreds of startups as a finalist for the ICI Innovation Award Competition.

Append Medical will also present in the Digital Presentations: Complex Coronary and Valvular Interventions program during the meeting.

December 18, 2019 — BioVentrix, Inc., developer of the first less invasive system for left ventricular remodeling, today announced online publication of positive one-year results from its CE Mark study of the Revivent TC System in the European Journal of Heart Failure. The paper will be published in print in the January issue of the journal.

December 18, 2019 — Cook Medical initiated a recall of its CrossCath Support Catheters in November, which the U.S. Food and Drug Administration (FDA) has identified this week as a Class I recall. The FDA said the devices may cause serious injuries or death.

The most popular content in the month of November on DAIC was by far the data from the late-breaking trials from the American Herart Association (AHA) 2019 meeting. The second item on this month's list is an overview of key heart failure takeaways from AHA by Nasrien Ibrahim, M.D., associate director of resynchronization and advanced cardiac therapeutics at Massachusetts General Hospital. Photo by Scott Morgan/AHA.

December 16, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of November 2019. This is based on the website’s 250,471 pageviews for the month:

1. American Heart Association 2019 Late-breaking Trials

2. Key Heart Failure Takeaways at AHA 2019
Vascepa pill contains a concentrated form of fish oil, icosapent ethyl, indication for prevention. The U.S. Food and Drug Administration (FDA) Dec. 13, 2019, approved the use of Vascepa (icosapent ethyl) capsules as an adjunctive therapy to reduce the risk of cardiovascular events in adults with elevated triglyceride levels.

The U.S. Food and Drug Administration (FDA) approved the use of Vascepa (icosapent ethyl) capsules as an adjunctive therapy to reduce the risk of cardiovascular events in adults with elevated triglyceride levels

Multimodality Cardiovascular Imaging for the Clinician

The Multimodality Cardiovascular Imaging for the Clinician conference taking place March 14-16, 2020 in Fort Lauderdale, Florida

 

December 12, 2019 — Impulse Dynamics, developer of Optimizer Smart System for delivering CCM therapy, announced the completion of an $80.25 million Series D financing with new investors. The proceeds will be used primarily to facilitate U.S.

December 12, 2019 — Low-dose aspirin was not associated with a reduced risk of a fatal heart attack among African Americans, according to an observational study published in the Journal of the American Heart Association, the open access journal of the American Heart Association.

December 12, 2019 — Cardiologs, a global leader in artificial intelligence (AI) cardiology diagnostics, announced today it has earned global industry analysts Frost & Sullivan’s New Product Innovation Award.

December 9, 2019 —  DiA Imaging Analysis Ltd., an IBM Alpha Zone Accelerator Alumni Startup, announces a collaboration with IBM Watson Health, a leading provider of innovative AI, enterprise imaging, and interoperability solutions used by medical professionals worldwide.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now